Global Health Ltd Share Price Target 2024, 2025 to 2030

Global Health Limited, operating under the brand name Medanta, is a prominent for-profit private hospital network headquartered in Gurgaon, India. Established in 2009 by renowned cardiac surgeon Dr. Naresh Trehan and entrepreneur Sunil Sachdeva, Medanta has grown into a leading healthcare provider in the country. The network is known for its state-of-the-art medical facilities, advanced technology, and a team of highly skilled healthcare professionals. Medanta offers a wide range of medical services, including cardiology, neurology, oncology, orthopedics, and organ transplantation, among others. With its commitment to excellence in healthcare and patient-centric approach, Medanta continues to set high standards in the Indian medical industry.

History of Global Health Ltd (MEDANTA)

Medanta’s journey began in 2004 when cardiac surgeon Naresh Trehan, along with Sunil Sachdeva, initiated the venture after Trehan left Escorts Heart Institute. Avenue Capital Group invested ₹224 crore (US$49.44 million) in 2006. The first hospital, Medanta – The Medicity, was launched in Gurgaon in 2009, a 1250-bed super-specialty facility built at a cost of about ₹1,200 crore (US$247.91 million). In 2013, Carlyle Group acquired Avenue Capital Group’s 27% stake for ₹960 crore (US$163.83 million), valuing the company at ₹3,550 crore (US$605.82 million). By 2015, Singapore-based Temasek Holdings had purchased Punj Lloyd’s 17.74% stake. Medanta expanded by launching a 160-bed hospital in Indore and acquiring the Abdur Razzaque Ansari Memorial Weavers’ Hospital in Ranchi. In 2018, it opened a 200-bed hospital in Sri Ganganagar, and in 2019, it began operations of a 1000-bed multi-specialty hospital in Lucknow, built at a cost of ₹1,000 crore (US$155.88 million). Although Manipal Hospitals planned to acquire Medanta for ₹5,800 crore (US$823.63 million) in 2019, the deal was called off. In 2021, Medanta inaugurated the 500-bed Jay Prabha Medanta Super Specialty Hospital in Patna and launched its initial public offering (IPO) in November 2022.

Medanta Q4 FY24 Net Profit Rises 25% to ₹127.3 Crore, Revenue Up 14%

• Net Profit Increase:
  • Medanta Hospitals operator Global Health Ltd reported a 25% year-on-year increase in net profit for Q4 FY24.
  • The net profit for the quarter was ₹127.3 crore, up from ₹101.8 crore in the same quarter last year.
• Revenue Growth:
  • Revenue from operations increased by 14% year-on-year.
  • The revenue for the quarter was ₹808 crore, compared to ₹707 crore in the year-ago period.
• Company Background:
  • Global Health Ltd, established in 2004 by Dr. Naresh Trehan, operates Medanta Medicity.
  • Medanta Medicity is a super-specialty tertiary-care hospital in Gurugram with a 1,400-bed capacity, which began operations in November 2009.
• Expansion and Operations:
  • In FY15, Medanta entered into an arrangement to manage 150-bed hospitals in Indore and Ranchi.
  • Medanta also operates hospitals in Lucknow and Patna.
  • A new hospital is being set up in Noida, Uttar Pradesh.

How to Purchase Global Health Ltd Shares in India?

Below are the trading platforms that you can use to purchase Global Health Ltd shares:

➤ Zerodha

➤ Upstox

➤ Groww

➤ AngelOne

➤ ICICIDirect

Global Health Ltd Share Price Prediction: 2024, 2025 to 2030

Global Health Ltd Share Price Target 2024

Global Health Ltd Share Price Prediction 2025

When	Maximum Price	Minimum Price
January 2025	1,437.50	1,105.77
February 2025	1,452.02	1,116.94
March 2025	1,482.51	1,140.39
April 2025	1,467.83	1,129.10
May 2025	1,425.08	1,096.21
June 2025	1,489.21	1,145.54
July 2025	1,460.01	1,123.08
August 2025	1,505.16	1,157.82
September 2025	1,523.22	1,171.71
October 2025	1,562.83	1,202.17
November 2025	1,601.90	1,232.23
December 2025	1,673.98	1,287.68

Global Health Ltd Share Price Target 2026

When	Maximum Price	Minimum Price
January 2026	1,724.20	1,326.31
February 2026	1,681.10	1,293.15
March 2026	1,714.72	1,319.02
April 2026	1,749.71	1,345.93
May 2026	1,732.39	1,332.61
June 2026	1,775.70	1,365.92
July 2026	1,740.88	1,339.14
August 2026	1,794.72	1,380.56
September 2026	1,830.62	1,408.17
October 2026	1,878.21	1,444.78
November 2026	1,925.17	1,480.90
December 2026	1,973.30	1,517.92

Global Health Ltd Share Price Target 2027

When	Maximum Price	Minimum Price
January 2027	2,184.91	1,680.70
February 2027	2,240.93	1,723.79
March 2027	2,328.33	1,791.02
April 2027	2,282.68	1,755.90
May 2027	2,216.19	1,704.76
June 2027	2,315.92	1,781.48
July 2027	2,270.51	1,746.54
August 2027	2,340.73	1,800.56
September 2027	2,422.66	1,863.58
October 2027	2,485.64	1,912.03
November 2027	2,547.79	1,959.84
December 2027	2,611.48	2,008.83

Global Health Ltd Share Price Prediction 2028

When	Maximum Price	Minimum Price
January 2028	2,663.71	2,049.01
February 2028	2,732.01	2,101.55
March 2028	2,838.56	2,183.51
April 2028	2,782.90	2,140.69
May 2028	2,701.85	2,078.34
June 2028	2,823.43	2,171.87
July 2028	2,768.07	2,129.28
August 2028	2,853.68	2,195.14
September 2028	2,953.56	2,271.97
October 2028	3,030.35	2,331.04
November 2028	3,106.11	2,389.31
December 2028	3,183.76	2,449.05

Global Health Ltd Share Price Target 2029

When	Maximum Price	Minimum Price
January 2029	3,247.44	2,498.03
February 2029	3,330.70	2,562.08
March 2029	3,460.60	2,662.00
April 2029	3,392.75	2,609.80
May 2029	3,293.93	2,533.79
June 2029	3,442.15	2,647.81
July 2029	3,374.66	2,595.89
August 2029	3,479.03	2,676.18
September 2029	3,600.80	2,769.84
October 2029	3,694.42	2,841.86
November 2029	3,786.78	2,912.91
December 2029	3,881.45	2,985.73

Global Health Ltd Share Price Prediction 2030

When	Maximum Price	Minimum Price
January 2030	3,959.08	3,045.44
February 2030	4,060.59	3,123.53
March 2030	4,218.96	3,245.35
April 2030	4,136.23	3,181.72
May 2030	4,015.76	3,089.04
June 2030	4,196.47	3,228.05
July 2030	4,114.18	3,164.76
August 2030	4,241.43	3,262.64
September 2030	4,389.88	3,376.83
October 2030	4,504.01	3,464.63
November 2030	4,616.61	3,551.24
December 2030	4,732.03	3,640.02

In January 2030, MEDANTA shares are projected to range between ₹3,045.44 and ₹3,959.08. By December 2030, the range is expected to widen to ₹3,640.02 to ₹4,732.03, indicating potential fluctuations throughout the year.

Financial Condition of Global Health Ltd: Last 5 Years

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	1,500	1,447	2,167	2,694	3,275
Expenses +	1,309	1,250	1,709	2,073	2,476
Operating Profit	192	197	458	621	799
OPM %	13%	14%	21%	23%	24%
Other Income +	44	31	39	64	75
Interest	57	73	86	86	74
Depreciation	115	123	130	150	173
Profit before tax	64	32	281	449	627
Tax %	43%	11%	30%	27%	24%
Net Profit +	36	29	196	326	478
EPS in Rs	7.36	5.81	7.75	12.16	17.81
Dividend Payout %	0%	0%	0%	0%	0%

Medanta has shown a consistent upward trend in its financial performance over the past five years. Sales increased significantly from ₹1,500 crore in March 2020 to ₹3,275 crore in March 2024, reflecting strong growth. Expenses rose from ₹1,309 crore to ₹2,476 crore over the same period, but operating profit also improved from ₹192 crore to ₹799 crore, with the operating profit margin (OPM) climbing from 13% to 24%. Other income saw a steady increase from ₹44 crore to ₹75 crore. Interest expenses remained relatively stable, while depreciation costs grew from ₹115 crore to ₹173 crore. Profit before tax surged from ₹64 crore to ₹627 crore, and the effective tax rate decreased from 43% to 24%. Net profit rose from ₹36 crore in March 2020 to ₹478 crore in March 2024. Earnings per share (EPS) improved from ₹7.36 to ₹17.81 during this period. Notably, the company maintained a 0% dividend payout throughout these years.

FAQs

What is Global Health Ltd current market capitalization?

Global Health Ltd current market capitalization stands at ₹34,047 crore.

What is Global Health Ltd current share price?

As of July 4th, 2024, Global Health Ltd current share price is ₹1,267.

What is Global Health Ltd share price target for 2025?

Global Health Ltd share price target for 2025 ranges from a minimum of ₹1,096.21 to a maximum of ₹1,673.98.

What is Global Health Ltd share price target for 2030?

The share price target for Global Health Ltd in 2030 is projected to range between ₹3,045.44 and ₹4,732.03.

What is Global Health Ltd current Price-to-Earnings (P/E) ratio?

Global Health Ltd current Price-to-Earnings (P/E) ratio stands at 71.2.

Also Read

• SNL Bearings Share Price Target 2024, 2025, 2026 To 2030
• Delhivery Share Price Target 2024, 2025 to 2030
• ZYDUS LIFESCIENCES SHARE PRICE TARGET 2024, 2025 TO 2030

Conclusion:

In conclusion, Global Health Ltd, operating under the brand name Medanta, has delivered strong Q4 results and exhibited Strong financial performance over the past years. With a 25% year-on-year increase in net profit and a 14% rise in revenue from operations in Q4 FY24, Medanta demonstrates effective management and strategic execution. The company’s consistent growth in sales, operating profit, and net profit, coupled with a healthy operating profit margin and efficient cost management, underscores its resilience and operational excellence. Furthermore, Medanta’s commitment to reinvesting profits for future growth opportunities is evident in its decision to maintain a 0% dividend payout. With its prominent presence in the Indian healthcare sector and a promising outlook, Medanta is poised to continue its upward trajectory, delivering value to its stakeholders and contributing positively to the healthcare landscape in India.

Having said that, we are not a financial advisor. Please consult a SEBI-registered financial advisor before trading Global Health Ltd. This post on Global Health Ltd share price target from 2024 to 2030 is for educational purposes only.